Investor Relations Captor Therapeutics ®
Notice convening the Ordinary Shareholders Meeting and documents relating to the Ordinary Shareholders Meeting
Current report no. 20/2023
Date of drafting: 30 May 2023.
Subject: Notice convening the Ordinary Shareholders Meeting and documents relating to the Ordinary Shareholders Meeting
Legal basis: Article 56(1)(2) of the Act on Offering – current and periodic information
The Board of Directors of Captor Therapeutics S.A., with its registered office in Wrocław (the “Company”), acting on the basis of Article 399 § 1 in connection with Articles 402¹ and 402² of the Commercial Companies Code, announces that the Ordinary Shareholders Meeting of the Company has been convened for 26 June 2023, at 2:00 p.m. and will be held in Wrocław at 9 Duńska (54-427 Wrocław), in the “DELTA” building.
The Company's Management Board provides the following in the appendix to this report:
- the full text of the announcement with the agenda of the Ordinary Shareholders Meeting (Appendix 1),
- draft resolutions to be discussed at the Ordinary Shareholders Meeting of the Company (Appendix 2);
- content of the resolution of the Supervisory Board giving a positive opinion on the draft resolutions to be discussed at the Ordinary Shareholders Meeting of the Company (Appendix 3);
- the remuneration report prepared by the Company's Supervisory Board for 2022 (Appendix 4);
- independent auditor's report on the performance of an assurance service providing reasonable assurance on the assessment of the Captor Therapeutics S.A. remuneration report for 2022 (Appendix 5);
- the report of the Company's Supervisory Board for 2022 (Appendix 6).